Egg Freezing Guide 2025 — Costs, Success Rates & Process

What Is Egg Freezing?

Egg freezing — technically called mature oocyte cryopreservation — is the process of hormonally stimulating the ovaries to produce multiple eggs, retrieving those eggs through a minimally invasive procedure, and preserving them at ultra-low temperatures for future use. When you are ready to attempt pregnancy, the eggs are warmed, fertilized with sperm (from a partner or donor), and one or more resulting embryos are transferred to the uterus.

For most of reproductive medicine's history, egg freezing was considered experimental — eggs are large, water-rich cells that are particularly vulnerable to ice crystal formation during conventional freezing. That changed decisively in 2012, when the American Society for Reproductive Medicine (ASRM) officially removed the "experimental" label from egg freezing, citing accumulated evidence showing that survival rates and pregnancy outcomes with frozen eggs were comparable to fresh eggs at experienced centers. The primary driver of that milestone was a single technological breakthrough: vitrification.

Today, mature oocyte cryopreservation is used in two broad contexts. Medical egg freezing (also called oncofertility or fertility preservation) is offered to women facing cancer treatment, major surgery, or other situations where ovarian function may be compromised. Elective egg freezing — sometimes called social egg freezing — is chosen by women who want to preserve their reproductive options while deferring childbearing for personal, relationship, or career reasons. Both categories have grown sharply over the past decade, and egg freezing is now one of the most frequently requested fertility services in the United States.

How Vitrification Works

The key breakthrough that transformed egg freezing from an experimental technique into a reliable clinical tool is vitrification — an ultra-rapid cryopreservation method that avoids the ice crystal formation that made older slow-freeze protocols so damaging to oocytes.

The Mechanism

An egg is approximately 120 micrometers in diameter and contains a large volume of intracellular water. During conventional slow freezing, that water has time to form ice crystals, which puncture cell membranes, disrupt the meiotic spindle (the structure that properly segregates chromosomes), and damage the zona pellucida (the egg's outer shell). The result: survival rates of only 50–60% with slow-freeze protocols — acceptable for sperm and embryos, but too damaging for the fragile oocyte.

Vitrification solves this problem through two simultaneous mechanisms:

1. Cryoprotectant loading: The egg is briefly exposed to high concentrations of cryoprotectant agents (typically ethylene glycol and DMSO, combined with sucrose) that replace most of the intracellular water through osmosis. With less free water inside the cell, there is far less material available to form ice.

2. Ultra-rapid cooling: The egg — loaded onto a thin carrier device — is plunged directly into liquid nitrogen at −196°C in under one second. Cooling occurs so rapidly (estimated at >20,000°C per minute) that the remaining intracellular fluid vitrifies — solidifying into a glass-like amorphous state rather than crystalline ice. No crystals form; no structural damage occurs.

Survival Rates: Vitrification vs. Slow Freeze

The clinical impact of this difference is dramatic. In a landmark 2010 study by Cobo et al. (PubMed 20347077), vitrified eggs demonstrated 80–95% survival rates versus 50–60% with slow-freeze methods, with fertilization and embryo development rates comparable to fresh eggs. This study — among others — directly contributed to the ASRM's 2012 policy change.

Long-Term Storage

A common patient concern is whether eggs deteriorate in storage over time. The evidence is reassuring: at −196°C, all biological activity and molecular degradation halt entirely. A 2017 review of long-term storage outcomes (PubMed 28697572) found no documented decline in egg quality, fertilization rates, or clinical outcomes for eggs stored for 5–10 years. Theoretically, eggs stored indefinitely at −196°C should remain viable, though human data beyond 10 years remains limited.

Who Should Consider Egg Freezing?

Medical Indications

Medical egg freezing is recommended — and in many cases urgently necessary — for women facing treatments or conditions that may permanently impair ovarian function:

• Cancer diagnosis: Chemotherapy (especially alkylating agents like cyclophosphamide) and pelvic radiation are both directly gonadotoxic. Women diagnosed with breast cancer, lymphoma, leukemia, or other malignancies are often referred for fertility preservation consultation before treatment begins. The American Society of Clinical Oncology (ASCO) guidelines on fertility preservation recommend that oncologists discuss fertility preservation with all reproductive-age patients as early as possible in their treatment planning.
• Surgical menopause risk: Surgeries for endometriosis, ovarian cysts, or other pelvic conditions may require removal of ovarian tissue. Egg freezing before surgery protects future fertility.
• Premature ovarian insufficiency (POI): Women with a family history of early menopause, Turner syndrome, fragile X premutation carrier status, or other POI risk factors may benefit from freezing eggs earlier than they otherwise would.
• Gender-affirming care: Trans women who are considering feminizing hormone therapy, which suppresses sperm production, and trans men who may undergo testosterone therapy or gender-affirming surgery, may wish to preserve reproductive options before beginning treatment.
• Autoimmune disease: Lupus, rheumatoid arthritis, and other autoimmune conditions requiring immunosuppressive or gonadotoxic medications can also threaten ovarian reserve.

Elective (Social) Egg Freezing

For women choosing to delay childbearing for non-medical reasons, the calculus involves balancing the realistic probabilities of success with the cost and physical demands of the process.

Who benefits most: Women who freeze eggs before age 35 achieve the best outcomes — eggs are more numerous, have a lower rate of chromosomal abnormality, and survive the freeze-thaw cycle more reliably. The ASRM's practice committee guidance on mature oocyte cryopreservation advises against egg freezing as a primary fertility preservation strategy for women over age 38, as the expected yield and per-egg live birth probability decline sharply beyond that threshold.

Psychological considerations: Several observational studies have found that egg freezing reduces "fertility anxiety" — the stress associated with the perceived ticking of a biological clock. However, clinicians and counselors note that frozen eggs are a form of insurance, not a guarantee. Many women who freeze eggs never use them; others who do use them do not achieve a live birth. Patients should approach elective egg freezing with realistic expectations grounded in their own test results, not in optimistic marketing.

Employer coverage: A growing segment of US employers now include egg freezing in their fertility benefits — Amazon, Apple, Google, Meta, and many others began covering it over the past decade. According to workforce surveys, approximately 77% of major US employers now offer some form of fertility benefit. Employer-sponsored coverage significantly reduces out-of-pocket cost and is often the deciding factor for patients considering elective freezing. See our egg freezing cost guide for current clinic pricing and state-by-state breakdowns.

The Egg Freezing Process — Step by Step

Step 1: Baseline Assessment (1–2 Weeks Before Stimulation)

Before any medications are prescribed, your reproductive endocrinologist will order a comprehensive ovarian reserve evaluation. This typically includes:

• AMH (Anti-Müllerian Hormone): Produced by granulosa cells in small follicles, AMH is the most reliable single marker of ovarian reserve. A high AMH (above ~3.0 ng/mL) suggests good reserve; very low AMH (below ~1.0 ng/mL) indicates diminished reserve and reduced expected egg yield.
• Day 3 FSH and Estradiol: Measured on the second or third day of a menstrual cycle. Elevated FSH (above ~10 mIU/mL) suggests the pituitary is working harder than normal to recruit follicles — an indirect sign of reduced reserve.
• Antral Follicle Count (AFC): A transvaginal ultrasound performed early in the cycle counts the number of small (2–10mm) follicles visible in both ovaries. AFC directly predicts how many eggs may develop in response to stimulation.

Expected egg yields by age (population-level estimates from SART data):

These numbers vary substantially depending on individual ovarian reserve — a 38-year-old with excellent AMH may produce more eggs than a 32-year-old with diminished reserve. Your AMH and AFC results will give you a personalized estimate.

Step 2: Ovarian Stimulation (8–14 Days)

Stimulation begins on day 2 or 3 of your menstrual cycle. You will self-inject hormonal medications daily, typically a combination of:

• FSH-dominant gonadotropins (Gonal-F, Follistim, or Menopur) to stimulate multiple follicles to grow simultaneously. In a natural cycle, only one follicle reaches maturity; stimulation encourages a cohort of follicles to develop in parallel.
• GnRH antagonist (Cetrotide or Ganirelix), typically started 5–6 days into stimulation, to prevent premature ovulation (spontaneous LH surge) before retrieval.

Self-injection is a common source of anxiety for patients, but the needles used are very fine, and most patients report that learning the technique takes only one or two sessions with a nurse.

Monitoring: You will return to the clinic every 1–3 days for transvaginal ultrasound to measure follicle size and blood estradiol to assess follicle activity. The clinic adjusts your medication dose based on response. Monitoring visits typically happen in the morning and are brief.

Side effects during stimulation are common and usually mild:

• Bloating and abdominal fullness (as developing follicles enlarge the ovaries)
• Breast tenderness
• Mood fluctuations (driven by elevated estrogen levels)
• Mild pelvic cramping or pressure

More serious side effects — discussed below under OHSS — are relatively uncommon with modern protocols.

Step 3: Trigger Shot

When the leading follicles reach approximately 18–20mm in diameter (typically after 8–12 days of stimulation), a "trigger" injection induces final egg maturation. Two trigger types are used:

• hCG (human chorionic gonadotropin): The traditional trigger. Effective but carries slightly higher risk of OHSS (see below).
• GnRH agonist (leuprolide acetate): Increasingly preferred for egg freezing cycles because it triggers ovulation through a different mechanism that does not carry the same OHSS risk. Because frozen-egg cycles have no fresh embryo transfer, the lower progesterone levels that follow a GnRH agonist trigger are not a concern — making it the preferred choice at many programs.

Timing is critical: the trigger must be administered exactly 34–36 hours before retrieval — not early, not late. Missing the timing window by even a few hours can result in premature ovulation (losing all eggs) or immature eggs that cannot be vitrified.

Step 4: Egg Retrieval

Egg retrieval is an outpatient procedure performed in the clinic or surgical center, typically under intravenous (IV) sedation. You will not be under general anesthesia in most cases, but you will be comfortable and unaware of the procedure.

The procedure itself takes 20–30 minutes:

1. A transvaginal ultrasound probe with a needle guide is inserted.
2. The needle is passed through the vaginal wall into each follicle under ultrasound visualization.
3. Follicular fluid is aspirated into a collection tube.
4. The embryologist at the adjacent lab immediately examines the fluid under a microscope to identify and grade recovered eggs.

After the procedure, you will rest in a recovery area for 1–2 hours until sedation wears off. You will need a driver. Most patients return to normal activity within 24–48 hours, though pelvic soreness and bloating are common for several days as the ovaries shrink back to normal size.

Typical yield: Of the eggs retrieved, approximately 70–80% will be mature (MII stage) — the only stage that can be vitrified. The remainder are either immature (germinal vesicle or MI stage) or post-mature, and most programs do not vitrify them.

Step 5: Vitrification

Within hours of retrieval, the embryologist identifies mature eggs under the microscope, strips away the surrounding cumulus cells, and processes them through the vitrification protocol — cryoprotectant loading followed by rapid plunge into liquid nitrogen. The entire process from retrieval to storage takes 2–4 hours.

Lab quality matters enormously. Vitrification is a technique-dependent procedure; survival rates vary significantly between laboratories. When evaluating clinics, ask specifically about their post-vitrification survival rates and whether their laboratory holds CAP (College of American Pathologists) and CLIA (Clinical Laboratory Improvement Amendments) accreditation — the gold standard for embryology lab quality in the US. See our guide to choosing a fertility clinic for a detailed framework.

Step 6: Storage

Frozen eggs are stored in cryogenic tanks containing liquid nitrogen at −196°C. Modern cryogenic tanks are designed for long-term, stable storage with multiple safety redundancies including alarm systems and backup liquid nitrogen supply.

Annual storage fees at most US clinics range from $500–$1,000 per year. Some clinics bundle one year of storage into the initial retrieval fee; others charge from day one. Before signing, confirm the storage fee in writing and ask what happens to your eggs if the clinic closes or is acquired.

As noted above, the scientific evidence indicates no quality decline over 5–10 years of storage.

Success Rates by Age

Age at the time of egg freezing is the single most important predictor of outcomes — not age at transfer. Eggs frozen at 32 will perform like 32-year-old eggs whether they are used at 35 or 42.

The following table represents population-level estimates based on SART national data and the Cobo et al. Fertility & Sterility 2016 outcomes analysis:

How Many Eggs Do You Need?

To achieve a >70% cumulative probability of at least one live birth, reproductive endocrinologists generally advise:

• Women under 35: approximately 15–20 mature eggs (achievable in one retrieval cycle for most patients)
• Women 35–37: approximately 15–20 mature eggs (may require one or two cycles)
• Women 38–40: approximately 20–25 mature eggs (often requires two retrieval cycles)
• Women over 40: outcomes are significantly more uncertain; two or more cycles may be recommended, and your physician may discuss the role of preimplantation genetic testing (PGT-A) when eggs are eventually used

These are probabilistic estimates. Your actual expected yield — and therefore the number of cycles likely needed — depends heavily on your individual AMH, AFC, and response to stimulation. Ask your physician to walk through your personal projections before starting. Also see our analysis of IVF success rates by age for related context on what happens when frozen eggs are ultimately used.

Costs — A Realistic Breakdown

Egg freezing involves several distinct cost components that are frequently quoted separately. Here is a transparent breakdown of what to expect at US clinics in 2025:

Important: Many patients require more than one retrieval cycle to accumulate a target egg number. A 39-year-old expecting to retrieve 5–8 mature eggs per cycle would need two cycles to reach 15 eggs — meaning total costs before any transfer could exceed $25,000–$35,000.

Insurance and Employer Benefits

Insurance coverage for egg freezing varies dramatically by state and employer. As of 2025:

• 20 states plus DC have passed some form of fertility insurance mandate, but coverage for elective egg freezing specifically is rare in state mandates. Medical egg freezing (for fertility preservation before cancer or other gonadotoxic treatment) is increasingly covered. Review your state's mandates at the RESOLVE infertility coverage map.
• Employer benefits are expanding rapidly in the tech and finance sectors. Amazon, Apple, Google, and Meta all cover egg freezing cycles and medications for employees. If you have access to employer fertility benefits, they can dramatically reduce out-of-pocket exposure — sometimes covering the entire retrieval cycle and medications.
• Financing: Most clinics partner with third-party fertility financing companies (CapexMD, Future Family, Prosper Healthcare Lending) offering installment payment options for uninsured patients.

Ovarian Hyperstimulation Syndrome (OHSS)

Ovarian Hyperstimulation Syndrome is the most significant medical risk of ovarian stimulation. It occurs when the ovaries respond excessively to hormonal stimulation, producing a large number of follicles and triggering fluid shifts out of the bloodstream and into the abdominal cavity.

Symptoms range from mild to severe:

• Mild: bloating, pelvic discomfort, nausea, mild weight gain
• Moderate: pronounced abdominal distension, vomiting, decreased urine output
• Severe (rare): significant ascites (fluid in abdomen), shortness of breath, blood clotting abnormalities, hospitalization required

Risk factors: Women with PCOS, high AMH, or high AFC are at greatest risk because they tend to produce the largest follicle cohorts.

Modern prevention: The adoption of GnRH agonist triggers (instead of hCG) in egg freezing cycles has dramatically reduced severe OHSS risk. Because frozen-egg cycles do not involve a fresh embryo transfer, there is no need to maintain high progesterone after retrieval — meaning the GnRH agonist trigger is appropriate for virtually all egg freezing patients. The ASRM guidelines on OHSS prevention and treatment provide the clinical framework most US programs follow.

Ask your clinic specifically: "Do you use a GnRH agonist trigger for egg freezing cycles, and what is your protocol if I develop moderate OHSS?"

In Vitro Maturation (IVM) — An Alternative for Select Patients

In Vitro Maturation (IVM) is a modified approach in which eggs are retrieved while still immature (before the follicles reach full size), and then matured in the embryology laboratory rather than inside the body. This eliminates the need for the heavy gonadotropin stimulation used in conventional egg freezing cycles.

Advantages:

• Dramatically lower OHSS risk — ideal for women with PCOS who are at extreme risk from standard stimulation
• Faster process — eggs can sometimes be retrieved in a shorter window, important for women who need urgent fertility preservation before starting chemotherapy
• Lower medication cost — stimulation protocols are lighter or absent

Limitations:

• IVM live birth rates have historically been approximately 30–40% lower than conventional IVF at the same age, though outcomes at specialized IVM centers have improved substantially. A 2018 review of IVM outcomes (PubMed 29861276) found that results in PCOS patients are increasingly comparable to conventional IVF, making IVM a genuinely competitive option for that population.
• IVM is not offered at all clinics. Ask specifically whether your center has an active IVM program with documented outcome data.
• The technique requires specialized embryologist training and laboratory protocols.

Who should ask about IVM:

• Women with PCOS or AMH above 5.0 ng/mL who are at high OHSS risk
• Women needing urgent preservation with limited time for a full stimulation cycle
• Women in whom stimulation medications are medically contraindicated

IVM is also relevant for some patients in the LGBTQ+ community — including same-sex female couples planning to use donor sperm with frozen eggs. For a full overview of how egg freezing integrates into family-building options for LGBTQ+ patients, see our LGBTQ+ fertility options guide.

Questions to Ask Your Egg Freezing Clinic

Before committing to a program, ask these 12 specific questions to evaluate both clinical quality and transparency:

1. What is your post-vitrification egg survival rate? Look for centers reporting consistently above 85%.
2. What fertilization rates do you achieve with previously frozen eggs? Benchmark: >70% at experienced centers.
3. What blastocyst development rate do you achieve from frozen eggs? Benchmark: >40–50% of fertilized eggs reaching blastocyst.
4. How many egg retrieval cycles does your center perform annually? Volume (>200 cycles/year) correlates with embryologist proficiency.
5. Is your laboratory CAP- and CLIA-accredited? Both accreditations should be current.
6. Who performs the vitrification — a dedicated embryologist or rotating staff? Dedicated lab staff generally produce more consistent results.
7. What stimulation protocol will you use for me, and why? Your physician should explain their choice based on your specific AMH and AFC.
8. Do you use GnRH agonist triggers for egg freezing cycles? If the answer is no, ask why.
9. What is your OHSS protocol if I over-respond? Ask about coast protocols, trigger modification, and cancellation thresholds.
10. What is included in the quoted price — monitoring visits, trigger medication, anesthesia? Get a written itemized quote.
11. What is the annual storage fee, and is it contractually fixed? Storage costs should be clear and guaranteed in writing.
12. What happens to my eggs if your clinic closes, merges, or is acquired? This is increasingly important as clinic consolidation accelerates.

Choosing the Right Clinic

Beyond the specific egg freezing questions above, selecting the right fertility center involves evaluating published SART data, staff credentials, and patient experience. Our detailed guide to choosing a fertility clinic walks through how to interpret clinic-specific outcome statistics, what questions to ask on a first consultation, and red flags to watch for in marketing language.

Frequently Asked Questions

Q: How does vitrification improve egg freezing outcomes compared to older slow-freeze methods? A: Vitrification plunges eggs into liquid nitrogen at over 20,000°C per minute, converting intracellular fluid to a glass-like amorphous state rather than crystalline ice. A landmark 2010 study by Cobo et al. demonstrated that vitrified eggs achieve 80–95% survival rates compared to only 50–60% with slow-freeze protocols, with fertilization and embryo development rates comparable to fresh eggs. This breakthrough directly led the ASRM to remove the "experimental" label from egg freezing in 2012.

Q: How many eggs do I need to freeze for a reasonable chance at a live birth? A: To achieve a greater than 70% cumulative probability of at least one live birth, reproductive endocrinologists generally advise women under 35 to freeze approximately 15–20 mature eggs (achievable in one retrieval cycle for most patients), women 35–37 to freeze 15–20 eggs (may require one or two cycles), and women 38–40 to freeze 20–25 eggs (often requiring two cycles). The estimated live birth rate per frozen mature egg is approximately 5–8% for women under 35, declining to 1–2% for women over 40.

Q: Do eggs deteriorate during long-term storage at -196°C? A: The evidence is reassuring: at -196°C, all biological activity and molecular degradation halt entirely. A 2017 review of long-term storage outcomes found no documented decline in egg quality, fertilization rates, or clinical outcomes for eggs stored for 5–10 years. Theoretically, eggs stored indefinitely at -196°C should remain viable, though human data beyond 10 years remains limited.

Q: What is the risk of ovarian hyperstimulation syndrome (OHSS) during egg freezing? A: OHSS occurs when the ovaries over-respond to stimulation medications. Mild OHSS (bloating, discomfort) is relatively common. Severe OHSS requiring hospitalization occurs in approximately 1–2% of cycles. Modern egg freezing protocols predominantly use GnRH agonist triggers instead of hCG, which dramatically reduces severe OHSS risk because frozen-egg cycles do not require a fresh embryo transfer, making the safer trigger universally appropriate.

Q: Is the ASRM's advice against egg freezing for women over 38 absolute? A: The ASRM practice committee advises against egg freezing as a primary fertility preservation strategy for women over 38 because expected egg yield and per-egg live birth probability decline sharply beyond that threshold. However, medical egg freezing (before cancer treatment) may still be strongly recommended regardless of age, and some women over 38 may choose elective freezing with realistic counseling about reduced expected outcomes. This is a decision to make with a reproductive endocrinologist based on individual AMH, AFC, and goals.

Related Resources

• Egg Freezing Cost by State
• Find Egg Freezing Clinics Near You
• How Many Eggs Should I Freeze?

This article was medically reviewed by Dr. Luis Arturo Ruvalcaba Castellón, MD — Founder & Director, Instituto Mexicano de Infertilidad (IMI); Medical Director, LIV Fertility Center, Guadalajara. Pioneered the first live birth from vitrified eggs in Latin America. Last reviewed April 2025.